A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective
Author:
Affiliation:
1. Division of Rheumatology, Department of Internal Medicine Yonsei University College of Medicine Seoul Korea
2. Patient Access Team Novartis Korea Seoul Korea
Funder
Novartis Korea
Publisher
Wiley
Subject
Rheumatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13635
Reference27 articles.
1. Ankylosing spondylitis
2. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age
3. Global prevalence of ankylosing spondylitis
4. Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
5. Efficacy and safety of TNF-α inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted therapies and conventional care for the treatment of ankylosing spondylitis in China: a cost-effectiveness analysis based on the network-meta analysis;Journal of Orthopaedic Surgery and Research;2024-08-18
2. Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis;Rheumatology and Therapy;2023-08-12
3. Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis;Doklady Biochemistry and Biophysics;2023-08
4. Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective;PharmacoEconomics - Open;2023-05-20
5. Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis;Rheumatology Science and Practice;2022-12-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3